The only international event dedicated to discussing regulatory, ethical and operational aspects of running clinical trials in Russia
30 November - 1 December 2021
Deputy Director of the Department for Pharmaceutical Drug Provision and Regulation of the Circulation of Medical Devices, Head of departmenr
Ministry of Health of Russian Federation
Head specialist medical devices circulation department
Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise "Center for Examinations and Tests in Health Service"
Deputy head to the section for coordination on the circulation of medicines and medical devices Department for Technical Regulation and Accreditation
Eurasian Economic Commission
Head
Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise "Center for Examinations and Tests in Health Service"
Head of Clinical Operations
Novartis Pharma
Director, Clinical Site Operations Russian Cluster
Pfizer
Head of Medical Projects Group
Takeda
Clinical Trials Director, Russia & EAEU countries
Servier
SMM Director, Oncology
AstraZeneca
Global Medical Director
Biocad
Head of Medical Department
GEROPHARM
Professor of Neonatology and Research Delivery
Institute of Life Course and Medical Sciences, University of Liverpool
Chief Medical Officer
R-Pharm
Medical devices department lector
RMANPO
Director
“Genome” Patient Support Centre
RWE Manager Russia, RWE Lead (CEE)
Novartis
Director of Clinical Research & Medical Affairs
AIPM Russia
Head of department of clinical trials
Sechenov University
Head of the Department for Pre-Clinical and Clinical Trials
National Medical Research Center of Oncology named after N.N. Petrov of the Ministry of Health of the Russian Federation
Head of Clinical Pharmacology Department
Pavlov First Saint Petersburg State Medical University
Сlinical trials Quality Assurance Manager
Drugs Technology
Associate Director, Operations
Statandocs
Director
Statandocs
Medical Director
Drugs Technology
Medical director
IPHARMA
President
Association of Oncology Patients “Zdravstvuy!”
Head of clinical research and experimental medicine department
Saint-Petersburg State University, Clinic of advanced medical technologies n. a. Nicolay I. Pirogov
Director
Sciencefiles
Head of clinical trials department
Drugs Technology (R-Pharm group of companies)
Co-Chair
Russian Patients Association
Medical Director, EAEU countries
R-Pharm
Country Head of Site Management
Bayer
Director, Institute for Personalized Medicine
Health Management Clinic, Sechenov University
Registration Engineer Lead
Elamed
Novartis
Neurologist, CSO
Prof. Y Shoenfeld Center of Autoimmune Diseases and Post-COVID Syndrome
Executive Director
Good Clinical Practice Alliance - Europe (GCPA), Belgium
Epidemologist, Center head of organisational and methodological work
Prof. Y Shoenfeld Center of Autoimmune Diseases and Post-COVID Syndrome
Consultant and Programme Coordinator
Pistoia Alliance
Head of the Department of Clinical Pharmacology
Yaroslavl State Medical University
Pharma Development Unit Head
Novartis Russia
Medical Projects Manager
Takeda Russia
Coordinator, Clinical Trials Division
Leningrad Regional Clinical Oncological Dispensary named after L. D. Roman
Oncologist
Leningrad Regional Clinical Oncological Dispensary named after L. D. Roman
Pre-clinical and clinical trials department expert
National Medical Research Center of Oncology named after N.N. Petrov of the Ministry of Health of the Russian Federation
Chairman
INTERNATIONAL UNION FOR PATIENT ASSISTANCE AND SUPPORT
Head of the Polyclinic Department
Kostroma Oncology Centre
Head of Pharmacology department, head of clinical research of medical products centre
Sechenov University
Head of Moscow Office
Interregional Public Organization of IBD and Short Bowel Syndrome Patients "Doverie"
Deputy Director for Educational Activities
N. N. Blokhin Russian Cancer Research Center
Deputy Director, Department of Clinical Trials
Sechenov University
President
All-Russian public organization of disabled people 'Russian Diabetic Association'
Head paediatrician of Moscow Region
Ministry of Health of Russia
Chairman of the Board
All-Russian Society of Orphan Diseases
KEY TOPICS & FEATURES IN 2021:
o The current status of the clinical trials market: what are the latest trends in Russia and globally?
o Clinical trials during the Covid-19 pandemic: practical experiences, challenges and solutions found
o Clinical trials in the Eurasian Union - registration practices and common rules in action
o Acceleration of digitalisation in clinical trials: AI, remote monitoring, electronic registers, access to data and data safety
o RWE - globally and in Russia: RWE as a key tool for the federal project “Digital technologies”
o Live Interviews with sponsors and research & investigators centres
Insights from 40+ experts: regulators, representatives of international and Russian pharmaceutical producers, CROs and investigators
2-day information-rich programme that includes insightful presentations from leading sector players, interactive debates and round tables
Unrivalled networking opportunities with 150+ attendees from such companies as AstraZeneca, Pfizer, Novartis, Bayer, Biocad, R-Pharm and many more
Unique opportunity for all the clinical trials sector players to meet and discuss the most burning issues.
The forum brings together representatives of all stakeholder groups involved in clinical trials – sponsors, CROs, regulators and investigators for a constructive dialogue aimed at improving all future processes.
Very good overview of a large number of clinical trial topics and the specifics of the Russian market.
Very interesting insight into the latest developments in the Russian market.
